Operating Lease, Right-of-Use Asset in USD of BALCHEM CORP from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BALCHEM CORP quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • BALCHEM CORP Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $15,916,000.000, a 2.37% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BALCHEM CORP Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $15,916,000 +$369,000 +2.4% 30 Sep 2025 10-Q 21 Oct 2025
Q2 2025 $15,655,000 -$814,000 -4.9% 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $15,598,000 -$1,375,000 -8.1% 31 Mar 2025 10-Q 24 Apr 2025
Q4 2024 $15,320,000 -$2,443,000 -13.8% 31 Dec 2024 10-Q 21 Oct 2025
Q3 2024 $15,547,000 -$519,000 -3.2% 30 Sep 2024 10-Q 25 Oct 2024
Q2 2024 $16,469,000 +$350,000 +2.2% 30 Jun 2024 10-Q 26 Jul 2024
Q1 2024 $16,973,000 +$1,741,000 +11.4% 31 Mar 2024 10-Q 03 May 2024
Q4 2023 $17,763,000 +$669,000 +3.9% 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 $16,066,000 +$4,449,000 +38.3% 30 Sep 2023 10-Q 27 Oct 2023
Q2 2023 $16,119,000 +$5,401,000 +50.4% 30 Jun 2023 10-Q 28 Jul 2023
Q1 2023 $15,232,000 +$8,331,000 +1.2% 31 Mar 2023 10-Q 28 Apr 2023
Q4 2022 $17,094,000 +$10,165,000 +1.5% 31 Dec 2022 10-K 16 Feb 2024
Q3 2022 $11,617,000 +$4,749,000 +69.1% 30 Sep 2022 10-Q 04 Nov 2022
Q2 2022 $10,718,000 +$3,610,000 +50.8% 30 Jun 2022 10-Q 29 Jul 2022
Q1 2022 $6,901,000 +$712,000 +11.5% 31 Mar 2022 10-Q 29 Apr 2022
Q4 2021 $6,929,000 +$1,091,000 +18.7% 31 Dec 2021 10-K 24 Feb 2023
Q3 2021 $6,868,000 +$1,322,000 +23.8% 30 Sep 2021 10-Q 29 Oct 2021
Q2 2021 $7,108,000 +$949,000 +15.4% 30 Jun 2021 10-Q 30 Jul 2021
Q1 2021 $6,189,000 -$723,000 -10.5% 31 Mar 2021 10-Q 30 Apr 2021
Q4 2020 $5,838,000 -$1,500,000 -20.4% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $5,546,000 -$1,055,000 -16% 30 Sep 2020 10-Q 28 Oct 2020
Q2 2020 $6,159,000 -$1,044,000 -14.5% 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $6,912,000 -$1,124,000 -14% 31 Mar 2020 10-Q 01 May 2020
Q4 2019 $7,338,000 +$7,338,000 31 Dec 2019 10-K 19 Feb 2021
Q3 2019 $6,601,000 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $7,203,000 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 $8,036,000 31 Mar 2019 10-Q 03 May 2019
Q4 2018 $0 31 Dec 2018 10-Q 05 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.